BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 872 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $431,000 | +6.7% | 4,927 | 0.0% | 0.34% | +8.7% |
Q2 2019 | $404,000 | 0.0% | 4,927 | -0.9% | 0.31% | -2.5% |
Q1 2019 | $404,000 | +21.0% | 4,974 | -1.9% | 0.32% | +25.3% |
Q4 2018 | $334,000 | -14.6% | 5,070 | 0.0% | 0.25% | -0.4% |
Q3 2018 | $391,000 | +4.5% | 5,070 | 0.0% | 0.25% | -7.0% |
Q2 2018 | $374,000 | +13.3% | 5,070 | 0.0% | 0.27% | +116.7% |
Q1 2018 | $330,000 | +9.6% | 5,070 | +9.0% | 0.13% | +35.5% |
Q4 2017 | $301,000 | +3.1% | 4,650 | 0.0% | 0.09% | -2.1% |
Q3 2017 | $292,000 | -6.1% | 4,650 | -9.4% | 0.10% | -12.8% |
Q2 2017 | $311,000 | +19.2% | 5,130 | +1.9% | 0.11% | +5.8% |
Q1 2017 | $261,000 | +20.3% | 5,033 | +2.7% | 0.10% | +28.8% |
Q4 2016 | $217,000 | +143.8% | 4,899 | +161.3% | 0.08% | +150.0% |
Q3 2016 | $89,000 | -5.3% | 1,875 | -9.3% | 0.03% | -27.3% |
Q2 2016 | $94,000 | -7.8% | 2,068 | -16.8% | 0.04% | 0.0% |
Q1 2016 | $102,000 | +7.4% | 2,486 | 0.0% | 0.04% | -10.2% |
Q4 2015 | $95,000 | +17.3% | 2,486 | +0.8% | 0.05% | +6.5% |
Q3 2015 | $81,000 | -11.0% | 2,466 | +89.7% | 0.05% | +4.5% |
Q2 2015 | $91,000 | +2.2% | 1,300 | 0.0% | 0.04% | -12.0% |
Q1 2015 | $89,000 | +9.9% | 1,300 | +18.2% | 0.05% | -16.7% |
Q4 2014 | $81,000 | – | 1,100 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |